{"prompt": "['50', 'MC1488 WEE1', 'MCCC', 'is necessary.', '13.6', 'A patient is deemed a major violation, if protocol requirements regarding treatment in', 'cycle 1 of the initial therapy are severely violated that evaluability for primary endpoint is', 'questionable. All data up until the point of confirmation of a major violation must be', 'submitted. The patient will go directly to the event monitoring phase of the study. Event', 'monitoring will be required per Section 18.0 of the protocol.', '13.7', 'A patient is deemed a cancel if he/she is removed from the study for any reason before', 'any study treatment is given. On-study material and the End of Active Treatment/Cancel', 'Notification Form must be submitted. No further data submission is necessary.']['51', 'MC1488', '14.0', 'Body Fluid Biospecimens', 'Body Fluid Biospecimen Submission', '14.1', 'Summary Table of Research Blood and Body Fluid Specimens to be Collected for this Protocol', 'At', 'Cycle', 'time of', 'EOS', '2 Day', 'Volume', 'bone', '5 (+1', 'Blood or', 'Type of', 'to collect', 'marro', 'Proces', 'Correlative', 'Collection', 'Cycle', 'Cycle', 'Day)', 'Temperature', 'Mandatory', 'Body', 'Study', 'per tube', 'W', 'S at', '1 Day', 'Conditions', 'Fluid', 'Tube', '(# of', 'Baseline', '1 Day', '& Day', 'or', 'after', 'site?', '(Section for', '2 (+1', '5 (+1', '5 of', 'Optional', 'being', '(color of', 'tubes to', 'more', 'Day)', 'Subse', 'cycles', '(Yes or', 'for Storage', 'Collected', 'be', 'Day)', '/Shipping', 'tube top)', '1', 'No)', 'information)', 'collected)', 'quent', 'Odd', '(AML', 'Cycles', 'only),', '2 and', '4\u00b3', '1 X Red', 'Whole', 'top', '10 mL', 'Biomarkers', 'Mandatory', '2 X Na', 'X', 'X\u00b9', 'X', 'X', 'Yes', 'Cold Pack', 'Blood', '(3)', 'Heparin', 'Green top', 'Bone', 'Hepariniz', '10 mL', 'Biomarkers', 'Mandatory', 'marrow', 'ed Green', 'X4', 'Yes', 'Cold Pack', '(2)', 'aspirate', 'top', 'X', 'X\u00b2', 'Buccal swab', 'Optional', 'Saliva', 'n/a', 'n/a', 'X', 'No', 'ambient', 'Pre-', 'Dose,', 'Pharmacokin', '1, 2, 4,', 'Lavender', 'Pre-', 'Mandatory', 'Plasma', '2 ml', '6, & 8', 'Yes', '-20\u00b0C', 'etics', 'Top', 'Dose', 'hrs', 'post-', 'dose', '1.', 'Only to be done in those patients with circulating tumor cells in their blood']['52', 'MC1488 WEE1', 'MCCC', '2.', \"End of study bone marrow sample is optional and to be collected only if bone marrow performed as part of patient's standard\", 'of', 'care.', '3.', 'Bone marrow aspirates will be done at times of standard clinical marrow tests. Follow Tables 4.1. (AML) and 4.2. (MDS) for study', \"schedule. In brief after cycle 1 (for AML only, at physician's discretion can be omitted, see Table 4), after cycles 2 and 4, and then\", 'at', 'physician discretion.', '4.', 'This is only mandatory IF a BM biopsy has not been done within 4 weeks of study start.', 'NOTE: marrow bisopies will not be done soley for the purpose of drawing a research sample, but should be performed to coincide at times of', 'standard clinical marrow biopsies/aspirates.']\n\n###\n\n", "completion": "END"}